Amelioration of alphavirus-induced arthritis and myositis in a mouse model by treatment with bindarit, an inhibitor of monocyte chemotactic proteins

Arthritis and Rheumatism

Volumn 60, Issue 8, 2009, Pages 2513-2523

  Rulli, Nestor E ^a   Guglielmotti, Angelo ^b   Mangano, Giorgina ^b   Rolph, Michael S ^a   Apicella, Claudia ^b   Zaid, Ali ^a   Suhrbier, Andreas ^c   Mahalingam, Suresh ^a  

^a UNIVERSITY OF CANBERRA   (Australia)

^b Università Politecnica delle Marche ACRAF Gruppo Angelini   (Italy)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BINDARIT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN; PROPIONIC ACID DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ALPHA VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CHIKUNGUNYA ALPHAVIRUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; MACROPHAGE; MAYARO ALPHAVIRUS; MONOCYTE; MOUSE; MYOSITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROSS RIVER ALPHA VIRUS; SINDBIS VIRUS; VIRUS INFECTION;

ALPHAVIRUS; ALPHAVIRUS INFECTIONS; ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; CELL LINE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HUMANS; INDAZOLES; MACROPHAGES; MICE; MICE, INBRED C57BL; MONOCYTE CHEMOATTRACTANT PROTEINS; MUSCLE, SKELETAL; MYOSITIS; PROPIONIC ACIDS; RNA, MESSENGER;

EID: 68049106284     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24682     Document Type: Article

References (48)

1. Suhrbier A, La Linn M. Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses. Curr Opin Rheumatol 2004;16:374-9.
2. Outbreak news. Chikungunya and dengue, south-west Indian Ocean. Wkly Epidemiol Rec 2006;81:106-8.
3. Outbreak news. Chikungunya, India. Wkly Epidemiol Rec 2006;81:409-10.
4. Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, et al. CHIKV study group. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007;370:1840-6.
5. Lanciotti RS, Ludwig ML, Rwaguma EB, Lutwama JJ, Kram TM, Karabatsos N, et al. Emergence of epidemic o'nyong-nyong fever in Uganda after a 35-year absence: genetic characterization of the virus. Virology 1998;252:258-68.
6. Harley D, Sleigh A, Ritchie S. Ross River virus transmission, infection, and disease: a cross-disciplinary review. Clin Microbiol Rev 2001;14:909-32.
7. Rulli N, Suhrbier A, Hueston L, Heise MT, Tupanceska D, Zaid A, et al. Ross River virus: molecular and cellular aspects of disease pathogenesis. Pharmacol Ther 2005;107:329-42.
8. Fraser JR. Epidemic polyarthritis and Ross River virus disease. Clin Rheum Dis 1986;12:369-88.
9. Mylonas AD, Brown AM, Carthew TL, McGrath B, Purdie DM, Pandeya N, et al. Natural history of Ross River virus-induced epidemic polyarthritis. Med J Aust 2002;177:356-60.
10. Harley D, Bossingham D, Purdie DM, Pandeya N, Sleigh AC. Ross River virus disease in tropical Queensland: evolution of rheumatic manifestations in an inception cohort followed for six months. Med J Aust 2002;77:352-5.
11. Morrison TE, Whitmore AC, Shabman RS, Lidbury BA, Mahalingam S, Heise MT. Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol 2006;80:737-49.
12. Lidbury BA, Rulli NE, Suhrbier A, Smith PN, McColl SR, Cunningham AL, et al. Macrophage-derived pro-inflammatory factors contribute to the development of arthritis and myositis following infection with an arthrogenic alphavirus. J Infect Dis 2008;197:1585-93.
13. Lidbury BA, Simeonovic C, Maxwell GE, Marshall ID, Hapel AJ. Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice. J Infect Dis 2000;181:27-34.
14. Fraser JR, Cunningham AL, Clarris BJ, Aaskov JG, Leach R. Cytology of synovial effusions in epidemic polyarthritis. Aust N Z J Med 1981;11:168-73.
15. Szekanecz Z, Koch AE. Macrophages and their products in rheumatoid arthritis. Curr Opin Rheumatol 2007;19:289-95.
16. Asquith DL, McInnes IB. Emerging cytokine targets in rheumatoid arthritis. Curr Opin Rheumatol 2007;19:246-51.
17. Tak PP. Chemokine inhibition in inflammatory arthritis. Best Prac Res Clin Rheumatol 2006;20:929-39.
18. Mateo L, La Linn M, McColl SR, Cross S, Gardner J, Suhrbier A. An arthrogenic alphavirus induces monocyte chemoattractant protein-1 and interleukin-8. Intervirology 2000;43:55-60.
19. Guglielmotti A, D'Onofrio E, Coletta I, Aquilini L, Milanese C, Pinza M. Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-α production. Inflamm Res 2002;51:252-8.
20. Guglielmotti A, Aquilini L, D'Onofrio E, Rosignoli MT, Milanese C, Pinza M. Bindarit prolongs survival and reduces renal damage in NZB/W lupus mice. Clin Exp Rheumatol 1998;16:149-54.
21. Zoja C, Corna D, Benedetti G, Morigi M, Donadelli R, Guglielmotti A, et al. Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease. Kidney Int 1998;53:726-34.
22. Bhatia M, Ramnath RD, Chevali L, Guglielmotti A. Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2005;288:1259-65.
23. Sironi M, Guglielmotti A, Polentarutti N, Fioretti F, Milanese C, Romano M, et al. A small synthetic molecule capable of preferentially inhibiting the production of the CC chemokine monocyte chemotactic protein-1. Eur Cytokine Netw 1999;10:437-42.
24. Teixeira CR, Teixeira MJ, Gomes RB, Santos CS, Andrade BB, Raffaele-Netto I, et al. Saliva from Lutzomyia longipalpis induces CC chemokine ligand 2/monocyte chemoattractant protein-1 expression and macrophage recruitment. J Immunol 2005;175:8346-53.
25. Mirolo M, Fabbri M, Sironi M, Vecchi A, Guglielmotti A, Mangano G, et al. Impact of the anti-inflammatory agent bindarit on the chemokinome: selective inhibition of the monocyte chemotactic proteins. Eur Cytokine Netw 2008;19:119-22.
26. Perico N, Benigni A, Remuzzi G. Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection. Nat Rev Drug Discov 2008;7:936-53.
27. Kuhn RJ, Niesters HG, Hong Z, Strauss JH. Infectious RNA transcripts from Ross River virus cDNA clones and the construction and characterization of defined chimeras with Sindbis virus. Virology 1991;182:430-41.
28. Gerlag DM, Ransone L, Tak PP. The effect of a T cell-specific NF-κB inhibitor on in vitro cytokine production and collagen-induced arthritis. J Immunol 2000;165:1652-8.
29. Zare F, Bokarewa M, Nenonen N, Bergstrom T, Alexopoulou L, Flavell RA, et al. Arthritogenic properties of double-stranded (viral) RNA. J Immunol 2004;172:5656-63.
30. Tak PP, Firestein GS. NF-κB: a key role in inflammatory diseases. J Clin Invest 2001;107:7-11.
31. Mylonas AD, Harley D, Purdie DM, Pandeya N, Vecchio PC, Farmer JF, et al. Corticosteroid therapy in an alphaviral arthritis. J Clin Rheumatol 2004;10:326-30.
32. Dragomir E, Simionescu M. Monocyte chemoattractant protein-1 - a major contributor to the inflammatory process associated with diabetes. Arch Physiol Biochem 2006;112:239-44.
33. Dawson J, Miltz W, Mir AK, Wiessner C. Targeting monocyte chemoattractant protein-1 signalling in disease. Expert Opin Ther Targets 2003;7:35-48.
34. Kalinowska A, Losy J. Investigational CC chemokine receptor 2 antagonists for the treatment of autoimmune diseases. Expert Opin Investig Drugs 2008;17:1267-79.
35. Brown CR, Blaho VA, Loiacono CM. Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattractant protein-1 production in joints and requires neutrophil recruitment via CXCR2. J Immunol 2003;171:893-901.
36. Erwig LP, Henson PM. Immunological consequences of apoptotic cell phagocytosis. Am J Pathol 2007;171:2-8.
37. Lidbury B, Mahalingam S. Specific ablation of antiviral genes in macrophages by antibody dependent enhancement of Ross River virus infection. J Virol 2000;74:8376-81.
38. Linn ML, Mateo L, Gardner J, Suhrbier A. Alphavirus-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages. J Virol 1998;72:5146-53.
39. Biswas SK, Sodhi A. In vitro activation of murine peritoneal macrophages by monocyte chemoattractant protein-1: up-regulation of CD11b, production of proinflammatory cytokines, and the signal transduction pathway. J Interferon Cytokine Res 2002;22:527-38.
40. Ackermann C, Kavanaugh A. Tumor necrosis factor as a therapeutic target of rheumatologic disease. Expert Opin Ther Targets 2007;11:1369-84.
41. Amin AR, Attur M, Abramson SB. Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis. Curr Opin Rheumatol 1999;11;202-9.
42. Yin W, Hasunuma T, Kobata T, Sumida T, Nishioka K. Synovial hyperplasia in HTLV-I associated arthropathy is induced by tumor necrosis factor α produced by HTLV-I infected CD68+ cells. J Rheumatol 2000;27:874-81.
43. Lechner F, Vogt HR, Seow HF, Bertoni G, Cheevers WP, von Bodungen U, et al. Expression of cytokine mRNA in lentivirus-induced arthritis. Am J Pathol 1997;151:1053-65.
44. Kerr JR, Cunniffe VS, Kelleher P, Coats AJ, Mattey DL. Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis. J Med Virol 2004;74:147-55.
45. Winthrop KL. Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor. Nat Clin Pract Rheumatol 2006;2:602-10.
46. Rahman MM, McFadden G. Modulation of tumor necrosis factor by microbial pathogens. PLoS Pathog 2006;2:e4.
47. Berger RG, Raab-Traub N. Acute monoarthritis from infectious mononucleosis. Am J Med 1999;107:177-8.
48. Wilkerson MJ, Davis WC, Baszler TV, Cheevers WP. Immunopathology of chronic lentivirus-induced arthritis. Am J Pathol 1995;146:1433-43.